Allogeneic Mesenchymal Stem Cell-based treatments legislation in Latin America: The need for standardization in a medical tourism context

Post time 2022-3-7 11:55:51

revista：Células Madre y Desarrollo

Autores：Tanya Estefanía Orozco-Solares; Lilia Carolina León-Moreno; Andrea Rojas-Rizo; Karen Manguart-Paez; Arnold I. Caplan

Fecha de publicación: 25/Feb/2022

DOI：10.1089/scd.2022.0013

Enlace del artículo：http://dx.doi.org/10.1089/scd.2022.0013

Fuente del artículo: Mary Ann Liebert Inc.。

Observación:

Post time 2022-3-7 11:55:52

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-3-27 23:30:37

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Liebert] Allogeneic Mesenchymal Stem Cell-based treatments legislation in Latin America: The need for standardization in a medical tourism context

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today